Skip to main navigation Skip to search Skip to main content

Molecular characterization of colorectal cancer related peritoneal metastatic disease

  • Kristiaan J. Lenos*
  • , Sander Bach
  • , Leandro Ferreira Moreno
  • , Sanne ten Hoorn
  • , Nina R. Sluiter
  • , Sanne Bootsma
  • , Felipe A. Vieira Braga
  • , Lisanne E. Nijman
  • , Tom van den Bosch
  • , Daniel M. Miedema
  • , Erik van Dijk
  • , Bauke Ylstra
  • , Ruth Kulicke
  • , Fred P. Davis
  • , Nicolas Stransky
  • , Gromoslaw A. Smolen
  • , Robert R.J. Coebergh van den Braak
  • , Jan N.M. IJzermans
  • , John W.M. Martens
  • , Sally Hallam
  • Andrew D. Beggs, Geert J.P.L. Kops, Nico Lansu, Vivian P. Bastiaenen, Charlotte E.L. Klaver, Maria C. Lecca, Khalid El Makrini, Clara C. Elbers, Mark P.G. Dings, Carel J.M. van Noesel, Onno Kranenburg, Jan Paul Medema, Jan Koster, Lianne Koens, Cornelis J.A. Punt, Pieter J. Tanis, Ignace H. de Hingh, Maarten F. Bijlsma, Jurriaan B. Tuynman, Louis Vermeulen*
*Corresponding author for this work
  • University of Amsterdam
  • Oncode Institute (Nederland)
  • Vrije Universiteit Amsterdam
  • Celsius Therapeutics
  • University of Birmingham
  • University Medical Centre Utrecht
  • Amsterdam UMC
  • Maastricht University

Research output: Contribution to journalArticleAcademicpeer-review

106 Citations (Scopus)
123 Downloads (Pure)

Abstract

A significant proportion of colorectal cancer (CRC) patients develop peritoneal metastases (PM) in the course of their disease. PMs are associated with a poor quality of life, significant morbidity and dismal disease outcome. To improve care for this patient group, a better understanding of the molecular characteristics of CRC-PM is required. Here we present a comprehensive molecular characterization of a cohort of 52 patients. This reveals that CRC-PM represent a distinct CRC molecular subtype, CMS4, but can be further divided in three separate categories, each presenting with unique features. We uncover that the CMS4-associated structural protein Moesin plays a key role in peritoneal dissemination. Finally, we define specific evolutionary features of CRC-PM which indicate that polyclonal metastatic seeding underlies these lesions. Together our results suggest that CRC-PM should be perceived as a distinct disease entity.

Original languageEnglish
Article number4443
JournalNature Communications
Volume13
Issue number1
DOIs
Publication statusPublished - 4 Aug 2022

Bibliographical note

© 2022. The Author(s).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Molecular characterization of colorectal cancer related peritoneal metastatic disease'. Together they form a unique fingerprint.

Cite this